Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Study Number

4125024

Phase

N/A

Age Group

Adult

Principal Investigator

Shernan Holtan

Purpose

The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.

Check your eligibility for this trial

Check now

Full Title

A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

ClinicalTrials.Gov ID

NCT06450925

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.